U.S., Sept. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07843498) titled 'A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity' on Sept. 11.
Brief Summary: This study will evaluate the efficacy and safety of petrelintide compared with placebo, in conjunction with a reduced-calorie diet and increased physical activity, for weight management in participants living with overweight or obesity, at least one weight-related comorbidity, and without Type 2 Diabetes (T2D).
Study Start Date: Sept. 30
Study Type: INTERVENTIONAL
Condition:
Obesity or Overweight
Intervention:
COMBINATION_PRODUCT: Petrelintide
Petrelintide will be administered subcutan...